129 related articles for article (PubMed ID: 10820424)
1. Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.
Karaberis E; Mourelatos D
Teratog Carcinog Mutagen; 2000; 20(3):141-6. PubMed ID: 10820424
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S
Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in vitro.
Nikolaropoulos S; Tsavdaridis D; Arsenou E; Papageorgiou A; Karaberis E; Mourelatos D
Anticancer Res; 2000; 20(4):2745-51. PubMed ID: 10953353
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
5. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
Pantazis P; Han Z; Balan K; Wang Y; Wyche JH
Anticancer Res; 2003; 23(5A):3623-38. PubMed ID: 14666658
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and cytogenetic effects of esteric (ASE) and amidic (ASA) steroidal derivative of p-bis (2-chloroethyl) amino phenylacetic acid (CAPA). A comparative study.
Nikolaropoulos SS; Arsenou ES; Papageorgiou A; Mourelatos D
Anticancer Res; 1997; 17(6D):4525-9. PubMed ID: 9494562
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11).
Digkas E; Kareli D; Chrisafi S; Passadaki T; Mantadakis E; Hatzimichail A; Vargemezis V; Lialiaris T
Food Chem Toxicol; 2010 Jan; 48(1):242-9. PubMed ID: 19819285
[TBL] [Abstract][Full Text] [Related]
11. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
Catsoulacos P; Camoutsis C; Papageorgiou A
Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
[TBL] [Abstract][Full Text] [Related]
13. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
Zamboni WC; Strychor S; Joseph E; Parise RA; Egorin MJ; Eiseman JL
Cancer Chemother Pharmacol; 2008 Aug; 62(3):417-26. PubMed ID: 17957368
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Conover CD; Greenwald RB; Pendri A; Shum KL
Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
[TBL] [Abstract][Full Text] [Related]
15. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
[TBL] [Abstract][Full Text] [Related]
17. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and antineoplastic effects by newly synthesised steroidal alkylators in lymphocytic leukaemia P388 cells in vivo.
Mourelatos C; Kareli D; Dafa E; Argyraki M; Koutsourea A; Papakonstantinou I; Fousteris M; Pairas G; Nikolaropoulos S; Lialiaris TS
Mutat Res; 2012 Jul; 746(1):1-6. PubMed ID: 22464985
[TBL] [Abstract][Full Text] [Related]
20. Study of chromosome damage in patients with breast cancer treated by two antineoplastic treatments.
Silva LM; Takahashi CS; Carrara HH
Teratog Carcinog Mutagen; 2002; 22(4):257-69. PubMed ID: 12111710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
